Huntington Disease, also known as Huntington’s chorea, is an autosomal dominant inherited rare disorder that causes progressive degeneration of nerve cell of brain, leading to deterioration of a person’s physical and mental abilities. Huntington Disease symptoms are usually detected at the age of 30-50 and gets worse over 10 to 25 year period from the onset of disease.
Growth of the Huntington’s Disease Treatment Market is driven by rising prevalence of disease and increasing R&D programs by institutes and universities. According to Huntington’s disease Society of America, there are approximately 30,000 symptomatic people in the U.S. and over 200,000 at-risk of inheriting the disease. Organization such as CHID Foundation, Hereditary Disease Foundation, Huntington's Disease Society of America, and International Huntington Association aid in creating awareness among patients and their family, which is also expected to support growth of the Huntington’s disease treatment market.
Key Competitors in the Huntington Disease Treatment Industry:
1) Bausch Health Companies Inc.
Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals International, Inc.) is a Canadian multinational specialty pharmaceutical company. It develops, manufactures and markets pharmaceutical products and branded generic drugs, primarily for skin diseases, gastrointestinal disorders, eye health and neurology. Bausch Health owns Bausch & Lomb, a supplier of eye health products. The company was founded in the year 1959, and the headquarters are located in Laval, Quebac, Canada. The company was founded by Milan Panic.
2) SOM Innovation Biotech.
SOM Biotech is a private pharmaceutical company focused on the accelerated discovery and development of therapies for orphan diseases through a proprietary artificial intelligence-based drug discovery technology and developing strategic partnerships with major research centers and pharmaceutical companies. The company was founded in the year 2009, and the headquarters are located in Barcelona, Spain.
As of May 2022, SOM Biotech announced that it has signed a licensing agreement with the University of Minnesota, following the completion of research under a sponsored research agreement.
3) Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. (also known as Teva Pharmaceuticals) is an Israeli multinational pharmaceutical company Commission of autoimmune diseases, from the European. It specializes primarily in generic drugs, but other business interests include active pharmaceutical ingredients and, to a lesser extent, proprietary pharmaceuticals. Teva's facilities are located in Israel, North America, Europe, Australia, and South America. The company was founded in the year 1901, and the headquarters are located in Tel Aviv, Israel.
On 28 January 2020, the company announced that the Food and Drug Administration (FDA) had approved an autoinjector device for Ajovy (fremanezumab-vfrm) injection.
4) GlaxoSmithKline GSK plc.
GSK Plc. Is a British Multinational pharmaceutical and biotechnology company founded in the year 2000. The headquarters are located in London, England, UK. GlaxoSmithKline is the tenth largest pharmaceutical company and has ranked 294th on the 2002 Fortune Globes 500. The company was founded by Joseph Nathan. The company manufacture products for major diseases like asthma, cancer, infections and mental health.
In April 2022, the company announced its plans of acquiring Sierra Oncology Inc. for U.S$ 1.9 Billion. In May 2022, GSK announced it would acquire Affinivax and its phase II 24- Valent pneumococcal vaccine candidate for up to $3.3 Billion.
5) Pfizer Inc.
Pfizer Inc. is a pharmaceutical and biotechnology company based in America. It was founded in the year 1849. Pfizer manufactures and produces vaccines and medicine related to oncology, neurology, cardiology, and immunology. The corporation has produced various products that yield more than US$1 billion in annual revenue.
The company ranked 64th on the Fortune 500 and 49th on the Forbes Global 2000. The headquarters are located in New York City, U.S. and the products manufactured are sold worldwide. The company was founded by Charles Pfizer and Charles F. Erhart.
As of January 2023, Pfizer Inc. and Abzena have entered into an agreement under which Pfizer will be acquiring Abzena’s manufacturing facility in Sanford, North Carolina.
6) Vertex Pharmaceuticals
Vertex Pharmaceuticals is an American biopharmaceutical company. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. The Company develops drugs for the treatment of cystic fibrosis, cancer, inflammatory bowel, autoimmune disease, and neurological disorders. Vertex Pharmaceuticals serves healthcare sector worldwide.
In July 2022, the business announced it would acquire ViaCyte, Inc. for U.S. $320 million
7) Ipsen
Ipsen is a French biopharmaceutical company focused on transformative medicines in three therapeutic areas: oncology, rare disease and neuroscience. Ipsen is one of the world’s top 15 biopharmaceutical companies in terms of oncology sales. The company was founded in the year 1929, and the headquarters are located in Boulogne-Billancourt France. The company was founded by Henri Beaufour.
In August 2022, Ipsen successfully completed the acquisition of Epizyme and its lead medicine, Tazverik (tazemetostat), a first-in-class, chemotherapy-free EZH2a inhibitor for adults with relapsed or refractory follicular lymphoma (FL).
